NexGard for Dogs: The Science Behind How It Kills Fleas and Ticks
How does NexGard for dogs work? We break down the science of afoxolaner, its mechanism of action, safety profile, and what owners need to know.
Quick Answer: How Does NexGard for Dogs Work?
NexGard for dogs is an oral flea and tick preventive containing afoxolaner, a member of the isoxazoline drug class. After your dog chews the flavored tablet, afoxolaner is absorbed into the bloodstream. When a flea or tick bites your dog, it ingests the drug, which overstimulates the parasite's nervous system, causing rapid paralysis and death. NexGard kills fleas within 8 hours and ticks within 24-48 hours, providing one full month of protection per dose.
Always consult your veterinarian before starting any flea and tick preventive to confirm it's appropriate for your dog's age, weight, and health status.
The Pharmacology of Afoxolaner: What Makes NexGard Tick
NexGard (afoxolaner) was approved by the U.S. Food and Drug Administration in 2014 as the first oral isoxazoline-class parasiticide for dogs. Manufactured by Boehringer Ingelheim (originally developed by Merial), it represented a significant shift from topical spot-on treatments to systemic oral prevention.
Afoxolaner belongs to a chemical family called isoxazolines, which also includes fluralaner (Bravecto), sarolaner (Simparica), and lotilaner (Credelio). While they share a common mechanism, each has distinct pharmacokinetic profiles — meaning they're absorbed, distributed, metabolized, and excreted differently in your dog's body.
Mechanism of Action: GABA-Gated Chloride Channel Inhibition
Here's what happens at the molecular level when a flea or tick bites a NexGard-protected dog:
- Absorption: After oral administration, afoxolaner is absorbed through the gastrointestinal tract and reaches peak plasma concentrations within 2-4 hours. The drug has a high bioavailability — meaning most of the active ingredient actually enters the bloodstream rather than being destroyed by stomach acid or first-pass liver metabolism.
- Distribution: Afoxolaner distributes throughout the body via the blood, binding strongly to plasma proteins (over 99% protein-bound). This high protein binding is actually what gives NexGard its month-long duration — the drug slowly releases from protein reservoirs over time.
- Parasite exposure: When a flea or tick takes a blood meal, it ingests afoxolaner along with the blood. The drug then targets the parasite's GABA-gated chloride channels and glutamate-gated chloride channels in its nervous system.
- Neural disruption: GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in insects and arachnids. Afoxolaner blocks these chloride channels, preventing chloride ions from flowing into neurons. Without this inhibitory signaling, the parasite's neurons fire uncontrollably — leading to hyperexcitation, paralysis, and death.
- Selective toxicity: The reason afoxolaner kills parasites but not your dog lies in receptor selectivity. Mammalian GABA receptors have a structurally different configuration than arthropod GABA receptors. Afoxolaner has roughly 100x greater affinity for insect/acarine GABA receptors compared to mammalian ones, creating a wide safety margin.
Evolutionary Context: Why Parasite Resistance to Neurotoxins Matters
An Arms Race Millions of Years in the Making
The GABA neurotransmitter system that NexGard exploits is ancient — it evolved over 500 million years ago in the common ancestor of virtually all bilaterally symmetrical animals. In ancestral wild canids (wolves, coyotes, early domestic dogs), fleas and ticks were a constant pressure, but the parasites primarily caused irritation, anemia in heavy infestations, and transmitted diseases rather than posing an existential threat to the host.
What's scientifically interesting is that older classes of parasiticides — organophosphates, pyrethroids, carbamates — have seen significant resistance develop in flea populations over decades of use. This is classic evolutionary selection pressure: parasites with genetic mutations conferring resistance survive and reproduce. Isoxazolines like afoxolaner represent a newer target site that flea and tick populations have not yet widely developed resistance against, because these drugs have only been in use since 2014. However, veterinary parasitologists are actively monitoring for early signs of resistance development, and responsible rotation of drug classes is recommended in high-pressure environments like kennels and shelters.
The evolutionary story doesn't end there. Wild canids developed behavioral adaptations to manage ectoparasites — mutual grooming (allogrooming), dust bathing, and selecting resting sites with lower tick density. These behaviors reduced but never eliminated parasite loads. Modern oral preventives like NexGard achieve what behavioral adaptations could not: near-complete parasite control regardless of environment.
NexGard vs. Other Isoxazolines: A Pharmacokinetic Comparison
Not all oral flea and tick preventives work the same way inside your dog. Here's how NexGard (afoxolaner) compares to other drugs in its class:
| Parameter | NexGard (Afoxolaner) | Bravecto (Fluralaner) | Simparica (Sarolaner) | Credelio (Lotilaner) |
|---|---|---|---|---|
| Dosing interval | Monthly | Every 12 weeks (oral) or 8 weeks (topical) | Monthly | Monthly |
| Half-life in dogs | ~14-16 days | ~12-15 days (but extended efficacy due to tissue storage) | ~13 days | ~30 days |
| Minimum age | 8 weeks | 6 months (oral) | 6 months | 8 weeks |
| Minimum weight | 4 lb / 1.8 kg | 4.4 lb / 2 kg | 2.8 lb / 1.3 kg | 4.4 lb / 2 kg |
| Flea kill speed | Within 8 hours | Within 8 hours (oral) | Within 8 hours | Within 12 hours |
| Tick species covered | Black-legged, American dog, Lone star, Brown dog | Black-legged, American dog, Lone star, Brown dog | Black-legged, American dog, Lone star, Brown dog | Black-legged, American dog, Lone star, Brown dog |
| Typical cost per dose (2026) | $20-$30 | $45-$65 (per 12-week dose) | $20-$28 | $18-$26 |
| Heartworm coverage? | No (NexGard alone) | No | No | No |
Note: NexGard Spectra (not available in the US as of 2026 but available in Europe, Australia, and other markets) combines afoxolaner with milbemycin oxime to add heartworm and intestinal parasite coverage. US owners needing combination protection often pair NexGard with a separate heartworm preventive like Heartgard Plus.
Safety Profile: What the Data Actually Shows
Before FDA approval, afoxolaner underwent extensive safety testing. The pivotal field study, published in peer-reviewed veterinary literature, demonstrated that NexGard was safe and effective when administered to dogs at the labeled dose. However, the isoxazoline class carries an important safety consideration that every owner should understand.
The Neurological Adverse Event Question
In September 2018, the FDA issued a fact sheet for pet owners noting that isoxazoline-class drugs (including afoxolaner, fluralaner, sarolaner, and lotilaner) have been associated with neurological adverse events in some dogs. These events include:
- Muscle tremors
- Ataxia (uncoordinated movement)
- Seizures
These events were reported in dogs both with and without pre-existing seizure histories. The incidence rate is low — reported adverse events represent a small fraction of the millions of doses administered — but the FDA required updated labeling to alert owners and veterinarians.
When to Consult Your Veterinarian Before Using NexGard
Talk to your vet first if your dog:
- Has a history of seizures or epilepsy
- Is currently on other medications that lower the seizure threshold
- Has known liver or kidney disease (afoxolaner is metabolized hepatically and excreted primarily via bile/feces)
- Is pregnant, lactating, or intended for breeding (safety has not been conclusively established in these populations)
- Is under 8 weeks of age or under 4 lb (1.8 kg)
Your veterinarian can assess your dog's individual risk profile and recommend the most appropriate preventive.
Common, Typically Mild Side Effects
In clinical trials and post-market surveillance, the most commonly reported side effects of NexGard include:
- Vomiting — reported in approximately 1.7% of treated dogs in field studies
- Diarrhea — reported in approximately 1.4% of dogs
- Lethargy/drowsiness — reported in approximately 1.1% of dogs
- Decreased appetite — less commonly reported
- Pruritus (itching) — sometimes difficult to distinguish from the underlying flea allergy dermatitis the drug is treating
These are generally self-limiting and resolve within 24-48 hours without intervention. If vomiting occurs within 2 hours of administration, contact your vet — the dose may not have been fully absorbed and re-dosing may be necessary.
Common Misconceptions About NexGard Debunked
| Myth | Fact |
|---|---|
| "NexGard repels fleas and ticks." | NexGard does not repel parasites. Fleas and ticks must bite your dog to ingest afoxolaner. You may still see fleas on your dog — but they will die before they can lay eggs. This is a kill-on-contact misconception that applies to all oral isoxazolines. |
| "Natural flea preventives are safer than NexGard." | Essential oil-based repellents (pennyroyal, tea tree, citrus oils) can be toxic to dogs and lack FDA-reviewed efficacy data. Diatomaceous earth and brewer's yeast have no peer-reviewed evidence of flea prevention efficacy. NexGard has undergone rigorous FDA safety and efficacy evaluation. |
| "My dog had fleas while on NexGard, so it doesn't work." | Seeing fleas doesn't mean failure. Newly emerging fleas from the environment (carpets, yard, other pets) will jump onto your dog and bite before dying. The key metric is whether fleas are reproducing — if you're not seeing flea dirt or new generations, NexGard is breaking the life cycle. |
| "NexGard protects against heartworm." | NexGard (afoxolaner alone) does not prevent heartworm disease. You need a separate heartworm preventive (e.g., ivermectin-based or milbemycin-based products). In markets where NexGard Spectra is available, it includes milbemycin oxime for heartworm coverage. |
| "Bathing or swimming reduces NexGard's effectiveness." | Because NexGard is systemic (in the bloodstream), bathing, swimming, rain, and grooming have zero impact on its efficacy. This is a major advantage over topical spot-on treatments, which can be compromised by water exposure within 48 hours of application. |
How Afoxolaner Is Processed in Your Dog's Body: The Physiological Journey
Understanding the pharmacokinetics helps explain both NexGard's effectiveness and its limitations:
Phase 1 — Ingestion and Absorption (0-4 hours): NexGard is formulated as a beef-flavored chewable tablet. Afoxolaner is a lipophilic (fat-soluble) molecule, which means absorption is enhanced when given with food. The manufacturer recommends administering NexGard with or shortly after a meal. Peak blood plasma concentrations are typically reached within 2-4 hours post-dose.
Phase 2 — Distribution (4-48 hours): Once in the bloodstream, afoxolaner binds tightly to plasma proteins — primarily albumin. Over 99% of the drug is protein-bound at therapeutic concentrations. This creates a slow-release reservoir effect: as free afoxolaner is metabolized or excreted, protein-bound afoxolaner gradually dissociates to maintain therapeutic blood levels.
Phase 3 — Steady-State Efficacy (Days 1-28): Blood concentrations remain above the minimum effective concentration (MEC) for flea and tick kill throughout the 30-day dosing interval. Studies show that afoxolaner maintains effective concentrations against Ctenocephalides felis (cat flea, the most common flea on dogs) and multiple tick species for the full month.
Phase 4 — Elimination (ongoing): Afoxolaner is primarily eliminated via the hepatobiliary route — meaning the liver processes it and it's excreted in bile, then passed in feces. A small fraction is renally excreted. The elimination half-life of approximately 14-16 days means the drug gradually declines rather than abruptly stopping, which is why monthly dosing maintains consistent protection.
Practical Implications for Dog Owners
What NexGard Science Means for Your Daily Life
1. Give it with food. Because afoxolaner is lipophilic, administering NexGard on an empty stomach can reduce absorption by up to 40%. Always give the chewable with a meal or substantial snack containing some fat content.
2. Treat ALL pets in the household. NexGard kills adult fleas on your dog but doesn't sterilize the environment. Untreated cats, rabbits, or ferrets in the home serve as flea reservoirs. Use appropriate species-specific preventives for all household pets.
3. Expect to see dying fleas initially. In the first 24-48 hours after the first dose, you may see increased flea activity on your dog — this is actually the drug working. Fleas become hyperactive as their nervous systems are disrupted before they die. This is temporary.
4. Environmental management still matters. Flea pupae in carpets and bedding can remain viable for up to 5 months. NexGard breaks the reproductive cycle by killing adults before they lay eggs, but you'll need 2-3 consecutive months of treatment (plus vacuuming and washing bedding) to fully eliminate a household infestation.
5. Don't split or crush tablets. NexGard is dosed by weight class. Splitting tablets can result in uneven distribution of the active ingredient. If your dog is between weight classes, your vet will recommend the appropriate dose.
6. Set a monthly reminder. NexGard's protection wanes after approximately 30 days. Missing doses by even 3-5 days can create a gap where new fleas establish. Use a phone calendar or the NexGard app to set recurring reminders.
7. Watch for tick-borne disease symptoms even on prevention. No preventive is 100% effective, and ticks must feed briefly before dying. If your dog develops fever, lameness, lethargy, or loss of appetite during tick season, consult your vet for tick-borne disease testing (Lyme, Ehrlichia, Anaplasma).
Breed Considerations and Variations in Response
While afoxolaner is labeled for all dog breeds, some breed-specific factors warrant discussion with your veterinarian:
- MDR1 gene mutation breeds (Collies, Australian Shepherds, German Shepherds, Longhaired Whippets, and others): The MDR1 (ABCB1) gene encodes P-glycoprotein, a drug-efflux pump at the blood-brain barrier. Dogs with the MDR1 mutation have reduced ability to pump certain drugs out of the brain. While the Washington State University Veterinary Pharmacology Laboratory has not flagged afoxolaner as a high-risk drug for MDR1-mutant dogs at labeled doses, some veterinarians exercise extra caution with isoxazolines in known MDR1-positive dogs.
- Toy breeds under 4 lb (1.8 kg): NexGard is not labeled for dogs under 4 lb. Very small breeds like Chihuahuas, Yorkshire Terriers, and Pomeranians that fall below this threshold need an alternative preventive.
- Giant breeds over 121 lb (55 kg): NexGard's largest dose size covers dogs 51-121 lb. Dogs exceeding 121 lb may require veterinary guidance on appropriate dosing — do not simply double up tablets without consulting your vet.
- Herding breeds with seizure predisposition: Some herding breeds have higher baseline seizure rates. Discuss the risk-benefit analysis with your veterinarian, weighing the neurological risk against the disease risk from tick-borne illnesses.
When Parasite Behavior Signals a Bigger Problem
Flea and tick infestations can sometimes indicate underlying issues beyond simple parasite exposure:
- Recurring infestations despite consistent NexGard use may signal an environmental reservoir problem (wildlife in your yard, untreated neighboring properties, or a heavily contaminated indoor environment) rather than product failure.
- Excessive scratching with minimal visible parasites could indicate flea allergy dermatitis (FAD), where even a single flea bite triggers a severe allergic response. FAD requires veterinary diagnosis and may need additional anti-inflammatory treatment alongside parasite control.
- Sudden heavy tick loads may indicate a change in your environment — new brush clearing, a new hiking trail, or increased wildlife activity. Adjust your walking routes and perform thorough tick checks after outdoor activity.
- If your dog vomits the tablet within 2 hours of administration, contact your veterinarian. Re-dosing may be necessary, and your vet can advise on anti-emetic strategies for dogs with sensitive stomachs.
Frequently Asked Questions About NexGard for Dogs
Can dogs take NexGard and Heartgard at the same time?
Yes. Both products are manufactured by Boehringer Ingelheim (formerly Merial) and are designed to be used concurrently. NexGard covers fleas and ticks; Heartgard Plus covers heartworm and certain intestinal parasites. Many veterinarians recommend this combination for comprehensive protection. No drug-drug interactions between afoxolaner and ivermectin/pyrantel have been identified at labeled doses.
Is NexGard safe for puppies?
NexGard is labeled safe for puppies 8 weeks of age and older, weighing at least 4 lb (1.8 kg). Puppies younger than 8 weeks or lighter than 4 lb should not receive NexGard. Discuss age-appropriate alternatives with your veterinarian for very young puppies.
How is NexGard different from topical flea treatments for dogs?
Topical treatments (like Frontline Plus or Advantage II) are applied to the skin and spread across the body surface via sebaceous glands. They can be affected by bathing, swimming, rain, and individual variation in skin oil production. NexGard works systemically through the bloodstream, making it unaffected by water exposure. However, topicals can offer some repellent effect (especially permethrin-based products for dogs), while NexGard does not repel — parasites must bite to be killed.
What happens if I miss a NexGard dose?
Administer the missed dose as soon as you remember, then resume monthly dosing from that new date. If the gap between doses exceeds 30 days, your dog may have been unprotected during the gap period. Monitor for fleas and ticks, and consider a thorough tick check. In areas with high heartworm prevalence, a missed flea/tick dose is less critical than a missed heartworm preventive dose — but both should be addressed promptly.
Does NexGard kill fleas before they bite?
No. NexGard does not repel fleas or prevent biting. Fleas must attach and begin feeding to ingest afoxolaner. However, kill speed is fast — fleas begin dying within 4-8 hours of their first blood meal, and most are dead before they can lay eggs (which typically takes 24-48 hours after the first meal). This effectively breaks the reproductive cycle even though brief biting occurs.
Can NexGard cause seizures in dogs?
The FDA has noted that isoxazoline-class drugs, including afoxolaner, have been associated with neurological adverse events including seizures in a small number of dogs. These events have occurred in dogs both with and without prior seizure history. The overall incidence is very low relative to the tens of millions of doses dispensed. If your dog has a known seizure disorder, discuss the risk-benefit ratio with your veterinarian before starting any isoxazoline product.
References
- U.S. FDA Center for Veterinary Medicine — Fact Sheet on Isoxazoline Flea and Tick Products
- Merck Veterinary Manual — Ectoparasiticides Overview
- Washington State University College of Veterinary Medicine — Veterinary Pharmacology Laboratory (MDR1 Drug Sensitivity)
Robin Maitland
All our authors care for dogs every day — read more of their work on the authors page.
